Related Experiment Videos

Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy

M Yoneda1, A Chomyn, A Martinuzzi

  • 1Division of Biology, California Institute of Technology, Pasadena 91125.

Insights

Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) mutant mtDNA showed a replicative advantage, causing a rapid shift toward pure mutant genotypes in unstable cell lines. Stable cell lines maintained their mixed or mutant mtDNA composition.

Area of Science:

  • Genetics
  • Cell Biology
  • Mitochondrial Medicine

Background:

  • Mitochondrial DNA (mtDNA) mutations are linked to various human diseases, including MELAS.
  • Understanding mtDNA segregation dynamics is crucial for disease progression and therapeutic strategies.

Purpose of the Study:

  • To investigate the segregation patterns of mutant and wild-type mtDNA in human cells.
  • To identify factors influencing the shift towards mutant mtDNA genotypes in MELAS pedigrees.

Main Methods:

  • Constructed transformants by transferring human mitochondria from MELAS patients into mtDNA-less (rho 0) cells.
  • Analyzed genotype shifts in clonal cell lines using subcloning and growth rate measurements.

Main Results:

  • Five of 13 clonal cell lines rapidly shifted towards a pure mutant mtDNA genotype.
  • Eight cell lines, including 6 near homoplasmic for mutant mtDNA, maintained stable genotypes.
  • Intracellular replicative advantage of mutant mtDNA was identified as the primary driver of genotype shifts in unstable lines.

Conclusions:

  • Mutant mtDNA in MELAS can possess a replicative advantage, leading to rapid shifts in cellular genotype.
  • mtDNA segregation stability is influenced by the replicative capacity of mutant mtDNA, impacting disease phenotype.

Related Concept Videos